Skip to content

The preventive effect of PH determination of tracheotomy supracapsular drainage on ventilator-associated pneumonia in neurological intensive care unit in China:a randomized controlled trial

The preventive effect of PH determination of tracheotomy supracapsular drainage on ventilator-associated pneumonia in neurological intensive care unit in China:a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092145
Enrollment
Unknown
Registered
2024-11-11
Start date
2025-01-01
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ventilator-associated pneumonia(VAP)

Interventions

Experimental group:The PH value of the drainage above the tracheotomy sac was determined. Jejunal tube insertion was given when the PH value was less than 6, and botox injection was given when the PH
normal group:Basic care was also present in the intervention group, including: head elevation 30-45 degrees
Continuous enteral nutrient pumping
Oral care with chlorine-containing disinfectant
The intracapsular pressure of tracheotomy was maintained at 25-30cmH2O. The drainage above the tracheotomy sac is attracted every 4-6 hours
Patients with sedation wake up daily
Daily ventilator evacuation experiment.

Sponsors

Beijing Rehabilitation Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: If the patient has had an artificial airway for more than 48 hours, is over 18 years old, needs EN support and informed consent from the family, and the balloon pressure is monitored after admission, the balloon pressure is maintained at 25-30cmH2O, and the drainage fluid from the balloon is extracted with a syringe every 4-6 hours. If the patient's saliva is more than 3 ml at a time or the patient's saliva is seen flowing out through the mouth, Can be randomly assigned to the experimental group and the control group.

Exclusion criteria

Exclusion criteria: 1. Persistent pneumonia or pulmonary infiltration confirmed by chest radiography upon admission; 2. Low immune function 3. Active gastrointestinal bleeding or acute gastrointestinal perforation; 4. Severe esophageal varices; Cerebrospinal fluid rhinorrhea or transnasal surgery; 5. The throat or esophagus is narrow or obstructed, and cannot be inserted into the gastroscope or nasogastric tube; 6. Allergic to polyvinyl chloride nasal feeding tube; 7. Has undergone any major abdominal surgery (i.e. oesophageal, stomach, duodenal or pancreatic surgery) or any abdominal surgery in the past month; 8. Severe heart or lung insufficiency (i.e. severe hypertension, severe arrhythmia, active myocardial infarction, severe heart failure, severe asthma, severe respiratory failure, making it difficult to breathe while lying flat; 9. Jejunostomy or gastrostomy; 10.30 days after participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Ventilator-associated pneumonia;

Countries

China

Contacts

Public ContactYanyanYin

Beijing Rehabilitation Hospital Affiliated to Capital Medical University

yinyanyan678@163.com+86 134 6660 0717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026